1. Does race affect the long-term survival benefit of systemic therapy in pancreatic adenocarcinoma?. (2021) Authors: Irfan, A.; Fang, H.A.; Awad, S.; Alkashah, A.M.; Vickers, S.M.; Gbolahan, O.; Williams, G.; Heslin, M.J.; Dudeja, V.; Rose, J.B.; Reddy, S. Journal: HPB Issue: Volume 23(2021)Supplement 2 Page Start: S574 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Presence of Lymph Node Metastasis Has a Greater Impact on Survival in Black Patients with Pancreatic Cancer: An Effect of Tumor Biology or a Disparity in Treatment?. (2022) Authors: Fang, A.H.; Irfan, A.; Vickers, S.M.; Gbolahan, O.; Williams, G.R.; Outlaw, D.; Wang, T.N.-T.; Dudeja, V.; Rose, B.; Reddy, S. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The fate of resectable pancreatic adenocarcinoma following neoadjuvant chemotherapy. (2021) Authors: Irfan, A.; Rose, J.B.; Heslin, M.J.; Vickers, S.M.; Dudeja, V.; Gbolahan, O.; Reddy, S. Journal: HPB Issue: Volume 23(2021)Supplement 2 Page Start: S658 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗